NCT07535905 2026-04-17
REVIVE
University Health Network, Toronto
Phase 2 Not yet recruiting
Clinical Trials
10 trialsNCT04731376 2026-02-11
Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone
Emory University
Phase 1 Active not recruiting
NCT06191575 2025-12-22
7 Tesla MRI Neuroimaging in Testicular Cancer Patients With Hypogonadism and on Androgen Replacement Therapy
University of Southern California
Suspended
NCT04833426 2025-05-02
ENFORCE
Canisius-Wilhelmina Hospital
Phase 3 Recruiting
NCT03063125 2021-08-03
Perioperative Hypogonadism in Men Undergoing Radical Cystoprostatectomy for Bladder Cancer
University of Kansas Medical Center
Completed
NCT01206270 2018-09-25
ALCeP
University of Roma La Sapienza
Phase 2/3 Completed
NCT02240966 2016-07-14
Symptoms and Clinical Signs of Hypogonadism in Testicular Cancer Survivors
Rigshospitalet, Denmark
Completed
NCT02102646 2015-10-28
MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism
Herlev Hospital
Phase 4 Completed
NCT00177619 2014-02-11
Prevention of Osteoporosis in Men With Prostate Cancer on Androgen Deprivation Therapy (POP Study)
University of Pittsburgh
Phase 3 Completed
NCT00048841 2010-03-02
Prevention of Osteoporosis in Men With Prostate Cancer
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase 3 Completed